UPLOAD Filing
CAPRICOR THERAPEUTICS, INC.
Date: Sept. 16, 2025 · CIK: 0001133869 · Accession: 0000000000-25-010011
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290179
Letter
Re: Capricor Therapeutics, Inc. Registration Statement on Form S-3 Filed September 10, 2025 File No. 333-290179 Dear Karen G. Krasney Esq.:
September 16, 2025
Karen G. Krasney, Esq. Executive Vice President and General Counsel Capricor Therapeutics, Inc. 10865 Road to the Cure, Suite 150 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Rob Carlson, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 16, 2025 Karen G. Krasney, Esq. Executive Vice President and General Counsel Capricor Therapeutics, Inc. 10865 Road to the Cure, Suite 150 San Diego, CA 92121 Re: Capricor Therapeutics, Inc. Registration Statement on Form S-3 Filed September 10, 2025 File No. 333-290179 Dear Karen G. Krasney Esq.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rob Carlson, Esq. </TEXT> </DOCUMENT>